News in brief: Canopy expands Australian portfolio; Neurotech CEO departs; Elixinol completes US sale by Adam Sheldon September 8, 2026September 9, 2026 Nasdaq and Toronto-listed Canopy Growth has expanded its Australian portfolio with a suite of new products, […]
Argent inks binding agreement to buy AusCann’s CannPal stake by Adam Sheldon January 15, 2026January 15, 2026
Argent BioPharma secures A$11m facility to complete AusCann acquisition by Adam Sheldon November 17, 2025February 21, 2026
Argent BioPharma inks deal to acquire AusCann assets and IP by Martin Lane August 19, 2025August 21, 2025
Australian firm ECC Pharm expands footprint in Germany with double acquisition by Steve Jones August 29, 2024August 29, 2024
ECC Pharm to save ‘a fortune’ after offloading HAPA distribution division by Steve Jones June 20, 2024June 20, 2024
Clarity over German legal scheme paves way for AusCann-Eurocann deal by Steve Jones February 7, 2024February 7, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024July 11, 2024
